SCHEMBL6765245

SCHEMBL6765245

Cc1cc(C(=O)N2CCCC2C)c(C)cc1NC(=O)CNc1ccc(C(=N)N)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.42
ALDH1A1 P00352 2/20 0.42
NAMPT P43490 2/20 0.40
HSD11B1 P28845 1/20 0.40
HPGD P15428 2/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
PLAU P00749 2/20 0.38
HPN P05981 1/20 0.38
F2 P00734 3/20 0.37
MAPK1 P28482 1/20 0.37
F10 P00742 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
PRSS1 P07477 1/20 0.36
ITGB3 P05106 1/20 0.36
ITGA2B P08514 1/20 0.36
HTT P42858 1/20 0.36
PLG P00747 1/20 0.36
PLAT P00750 1/20 0.36
KLK1 P06870 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6572911 0.85 ALDH1A1 (0.44) GAAALDH1A1HSD11B1MEN1KMT2A
SCHEMBL6563410 0.80 GAA (0.40) GAAALDH1A1NAMPTHSD11B1HPGD
SCHEMBL6563626 0.77 F2 (0.43) GAAALDH1A1HSD11B1HPGDF2
SCHEMBL6565512 0.77 GAA (0.40) GAAALDH1A1NAMPTHSD11B1HPGD
SCHEMBL6571927 0.76 ALDH1A1 (0.47) GAAALDH1A1PLAUF2MAPK1
SCHEMBL6761997 0.75 F10 (0.48) ALDH1A1HPGDPLAUF2F10
SCHEMBL5099780 0.74 F10 (0.42) GAAALDH1A1NAMPTHSD11B1HPGD
SCHEMBL6564299 0.74 GAA (0.36) GAAALDH1A1NAMPTHSD11B1HPGD
SCHEMBL6565356 0.73 GAA (0.42) GAAALDH1A1NAMPTHSD11B1HPGD
Hydrochloric Acid SCHEMBL5091399 0.73 F10 (0.42) GAAALDH1A1NAMPTHSD11B1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040248897-A1 Substituted N-acylaniline derivatives, the preparation thereof, and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-12-09 US claimed
US-20040248897-A1 Substituted N-acylaniline derivatives, the preparation thereof, and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248897-A1 Substituted N-acylaniline derivatives, the preparation thereof, and their use as pharmaceutical compositions NAT1, CYP3A5, CYP3A7 GAA 454/4885ALDH1A1 669/4885NAMPT 1008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.